Shirley M (outubro de 2018). "Dinoprostone Vaginal Insert: A Review in Cervical Ripening". Drugs78 (15): 1615–1624. PMID30317521. doi:10.1007/s40265-018-0995-2.
Furuyashiki T, Narumiya S (marzo de 2011). "Stress responses: the contribution of prostaglandin E(2) and its receptors". Nature Reviews. Endocrinology7 (3): 163–75. PMID21116297. doi:10.1038/nrendo.2010.194. hdl:2433/156404.
Gomez I, Foudi N, Longrois D, Norel X (agosto de 2013). "The role of prostaglandin E2 in human vascular inflammation". Prostaglandins, Leukotrienes, and Essential Fatty Acids89 (2–3): 55–63. PMID23756023. doi:10.1016/j.plefa.2013.04.004.
Torres R, Picado C, de Mora F (xaneiro de 2015). "The PGE2-EP2-mast cell axis: an antiasthma mechanism". Molecular Immunology63 (1): 61–8. PMID24768319. doi:10.1016/j.molimm.2014.03.007.
ACOG Committee on Practice Bulletins -- Obstetrics (agosto de 2009). "ACOG Practice Bulletin No. 107: Induction of labor". Obstetrics and Gynecology114 (2 Pt 1): 386–97. PMID19623003. doi:10.1097/AOG.0b013e3181b48ef5.
McDonagh M, Skelly AC, Hermesch A, Tilden E, Brodt ED, Dana T, et al. (2021-03-22). "Cervical Ripening in the Outpatient Setting". AHRQ Comparative Effectiveness Reviews (Rockville (MD): Agency for Healthcare Research and Quality (US)). PMID33818996. doi:10.23970/ahrqepccer238.
Singh EJ, Zuspan FP (maio de 1974). "Prostaglandins: overview in obstetrics and gynecology". Journal of Reproduction and Fertility12 (5): 211–4. PMID4599109. doi:10.1530/jrf.0.0410211.
Bygdeman M (decembro de 1984). "The use of prostaglandins and their analogues for abortion". Clinics in Obstetrics and Gynaecology11 (3): 573–84. PMID6391777. doi:10.1016/S0306-3356(21)00617-8.
"Dinoprostone". The American Society of Health-System Pharmacists. Arquivado dende o orixinal o 16 de xaneiro de 2017. Consultado o 8 de xaneiro de 2017.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Furuyashiki T, Narumiya S (marzo de 2011). "Stress responses: the contribution of prostaglandin E(2) and its receptors". Nature Reviews. Endocrinology7 (3): 163–75. PMID21116297. doi:10.1038/nrendo.2010.194. hdl:2433/156404.
Rabow MW, Pantilat SE, Shah AC, Poree L, Steiger S (2020). Papadakis MA, McPhee SJ, Rabow MW, eds. "Acute Pain". Current Medical Diagnosis and Treatment 2020. New York, NY: McGraw-Hill Education. Consultado o 2020-08-04.
nih.gov
ncbi.nlm.nih.gov
Shirley M (outubro de 2018). "Dinoprostone Vaginal Insert: A Review in Cervical Ripening". Drugs78 (15): 1615–1624. PMID30317521. doi:10.1007/s40265-018-0995-2.
Xi M, Gerriets V (2020). "Prostaglandin E2 (Dinoprostone)". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID31424863.
Schlemmer M, Khoss A, Salzer HR, Wimmer M (xullo de 1982). "[Prostaglandin E2 in newborns with congenital heart disease]". Zeitschrift für Kardiologie71 (7): 452–7. PMID6958133.
Furuyashiki T, Narumiya S (marzo de 2011). "Stress responses: the contribution of prostaglandin E(2) and its receptors". Nature Reviews. Endocrinology7 (3): 163–75. PMID21116297. doi:10.1038/nrendo.2010.194. hdl:2433/156404.
Gomez I, Foudi N, Longrois D, Norel X (agosto de 2013). "The role of prostaglandin E2 in human vascular inflammation". Prostaglandins, Leukotrienes, and Essential Fatty Acids89 (2–3): 55–63. PMID23756023. doi:10.1016/j.plefa.2013.04.004.
Torres R, Picado C, de Mora F (xaneiro de 2015). "The PGE2-EP2-mast cell axis: an antiasthma mechanism". Molecular Immunology63 (1): 61–8. PMID24768319. doi:10.1016/j.molimm.2014.03.007.
Tenore JL (maio de 2003). "Methods for cervical ripening and induction of labor". American Family Physician67 (10): 2123–8. PMID12776961.
ACOG Committee on Practice Bulletins -- Obstetrics (agosto de 2009). "ACOG Practice Bulletin No. 107: Induction of labor". Obstetrics and Gynecology114 (2 Pt 1): 386–97. PMID19623003. doi:10.1097/AOG.0b013e3181b48ef5.
McDonagh M, Skelly AC, Hermesch A, Tilden E, Brodt ED, Dana T, et al. (2021-03-22). "Cervical Ripening in the Outpatient Setting". AHRQ Comparative Effectiveness Reviews (Rockville (MD): Agency for Healthcare Research and Quality (US)). PMID33818996. doi:10.23970/ahrqepccer238.
Singh EJ, Zuspan FP (maio de 1974). "Prostaglandins: overview in obstetrics and gynecology". Journal of Reproduction and Fertility12 (5): 211–4. PMID4599109. doi:10.1530/jrf.0.0410211.
Bygdeman M (decembro de 1984). "The use of prostaglandins and their analogues for abortion". Clinics in Obstetrics and Gynaecology11 (3): 573–84. PMID6391777. doi:10.1016/S0306-3356(21)00617-8.
"Dinoprostone". The American Society of Health-System Pharmacists. Arquivado dende o orixinal o 16 de xaneiro de 2017. Consultado o 8 de xaneiro de 2017.